DE3854857D1 - Verhütung und behandlung einer retrovirenkrankheit - Google Patents

Verhütung und behandlung einer retrovirenkrankheit

Info

Publication number
DE3854857D1
DE3854857D1 DE3854857T DE3854857T DE3854857D1 DE 3854857 D1 DE3854857 D1 DE 3854857D1 DE 3854857 T DE3854857 T DE 3854857T DE 3854857 T DE3854857 T DE 3854857T DE 3854857 D1 DE3854857 D1 DE 3854857D1
Authority
DE
Germany
Prior art keywords
immunogen
retrovirus
hiv
infectious
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3854857T
Other languages
English (en)
Other versions
DE3854857T2 (de
Inventor
Jonas Salk
Dennis J Carlo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immune Response Corp
Original Assignee
Immune Response Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immune Response Corp filed Critical Immune Response Corp
Publication of DE3854857D1 publication Critical patent/DE3854857D1/de
Application granted granted Critical
Publication of DE3854857T2 publication Critical patent/DE3854857T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
DE3854857T 1987-06-10 1988-06-09 Verhütung und behandlung einer retrovirenkrankheit Expired - Fee Related DE3854857T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6028087A 1987-06-10 1987-06-10
US20075288A 1988-05-31 1988-05-31
PCT/US1988/001955 WO1988009670A1 (en) 1987-06-10 1988-06-09 Prevention and treatment of retroviral disease

Publications (2)

Publication Number Publication Date
DE3854857D1 true DE3854857D1 (de) 1996-02-15
DE3854857T2 DE3854857T2 (de) 1996-08-22

Family

ID=26739775

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3854857T Expired - Fee Related DE3854857T2 (de) 1987-06-10 1988-06-09 Verhütung und behandlung einer retrovirenkrankheit

Country Status (14)

Country Link
EP (3) EP0317622B1 (de)
JP (1) JPH0720880B2 (de)
AT (1) ATE132374T1 (de)
AU (1) AU612383B2 (de)
CA (1) CA1336407C (de)
DE (1) DE3854857T2 (de)
DK (1) DK56389D0 (de)
FI (1) FI95871C (de)
IL (1) IL86675A (de)
NO (1) NO175846C (de)
OA (1) OA09037A (de)
RU (1) RU2111010C1 (de)
UA (1) UA27716C2 (de)
WO (1) WO1988009670A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0287226A1 (de) * 1987-03-23 1988-10-19 Hiver Limited Impfstoff
US5256767A (en) * 1987-06-10 1993-10-26 The Immune Response Corporation Retroviral antigens
US5227159A (en) * 1989-01-31 1993-07-13 Miller Richard A Anti-idiotype antibodies reactive with shared idiotopes expressed by B cell lymphomas and autoantibodies
WO1990015133A1 (en) * 1989-05-30 1990-12-13 Nippon Zeon Co., Ltd. Method of producing core structure of retro virus and particle produced thereby
FR2661834B1 (fr) * 1990-05-09 1995-01-27 Merieux Inst Procede de fabrication d'immunogenes de retrovirus et de vaccins contre les infections retrovirales, notamment hiv, et immunogenes et vaccins obtenus.
AU4685293A (en) * 1992-07-20 1994-02-14 Immune Response Corporation, The Prophylactic and therapeutic control of retroviral infections
ATE189697T1 (de) * 1994-03-22 2000-02-15 Immune Response Corp Inc Die hocheffiziente herstellung und isolierung von viruspartikeln
IT1271593B (it) * 1994-11-30 1997-06-04 Sanitaria Scaligera Spa Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716102A (en) * 1984-08-15 1987-12-29 Regents Of The University Of California Purified AIDS-associated virus ARV-2
DK507185A (da) * 1984-11-05 1986-05-06 Du Pont Fremgangsmaade til inaktivering af human tumor leukaemi virus iii
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III
AU600658B2 (en) * 1984-12-24 1990-08-23 Genentech Inc. Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use
DE3650011T2 (de) * 1985-04-08 1994-11-17 Genetic Systems Corp EXPRESSION UND DIAGNOSE MIT gag-KODIERTEN PEPTIDEN, DIE MIT ANTIKÖRPERN GEGEN LAV IMMUNOLOGISCH REAKTIV SIND.
NZ215867A (en) * 1985-04-19 1989-10-27 Hoffmann La Roche Aids envelope protein, dna vectors and method of production
WO1987002892A1 (en) * 1985-11-14 1987-05-21 President And Fellows Of Harvard College T-lymphotrophic virus
EP0250128A3 (de) * 1986-06-18 1988-06-08 American Registry of Pathology Von AIDS-Patienten isoliertes Virus
CA1341277C (en) * 1987-03-16 2001-07-31 Roland Keith Mcgready Anti-paratopic antibody and a method of its manufacture

Also Published As

Publication number Publication date
FI890603A0 (fi) 1989-02-08
WO1988009670A1 (en) 1988-12-15
NO890565D0 (no) 1989-02-09
OA09037A (en) 1991-03-31
EP0685236A1 (de) 1995-12-06
NO175846C (no) 1994-12-21
EP0317622B1 (de) 1996-01-03
NO175846B (de) 1994-09-12
EP0602761A1 (de) 1994-06-22
UA27716C2 (uk) 2000-10-16
CA1336407C (en) 1995-07-25
FI95871C (fi) 1996-04-10
EP0317622A1 (de) 1989-05-31
RU2111010C1 (ru) 1998-05-20
DK56389A (da) 1989-02-08
IL86675A (en) 1993-04-04
AU1962688A (en) 1989-01-04
FI95871B (fi) 1995-12-29
JPH0720880B2 (ja) 1995-03-08
ATE132374T1 (de) 1996-01-15
DE3854857T2 (de) 1996-08-22
FI890603A (fi) 1989-02-08
AU612383B2 (en) 1991-07-11
DK56389D0 (da) 1989-02-08
JPH02500440A (ja) 1990-02-15
NO890565L (no) 1989-02-09
EP0317622A4 (de) 1990-05-14

Similar Documents

Publication Publication Date Title
RU94042386A (ru) Вакцина против гепатита, содержащая 3-0-дезацилированный монофосфорил-липида, применение антигена гепатита для получения препарата для лечения гепатита, способ лечения гепатита
DE68927348D1 (de) Künstlicher impfstoff gegen aids-virus
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
DE69737736D1 (de) Induktion rev- und tat-spezifischer zytotoxischer t-zellen zur prävention und behandlung einer infektion durch humanen immundefizienz-virus (hiv)
DE69840383D1 (de) Ctl epitope des epstein-barr virus
EP0330359A3 (de) Zusammensetzung, verwendbar zur Diagnose und Behandlung von HIV-I-Infektion
EP1375511A3 (de) Peptide zum Induzieren einer Antwort der zytotoxischen T-Lymphozyten gerichtet gegen das Hepatitis-B-Virus
BG98522A (en) Peptides including cytotoxic t-lymphocytic response to the virus of hepatite b
DE3854857D1 (de) Verhütung und behandlung einer retrovirenkrankheit
ATE188484T1 (de) Immunologisch mit hla homologe hiv protein epitope
ATE108335T1 (de) Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen.
FR2385401A1 (fr) Vaccin a virus respiratoire syncytial
ATE284709T1 (de) Virale chimären aus caev und hiv-1 genetischen elementen
DE69707680D1 (de) Caprin arthritis-enzephalitis virus enthaltende vakzine und verwendung zur immunschutz gegen hiv-1 infektion
ITRM950209A1 (it) Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
ATE111485T1 (de) Peptidbehandlung von hartnäckigen infektionskrankheiten.
HUP0003511A2 (hu) Hepatitisz-B-vírus polipeptidek
HUP0202389A2 (hu) Macskafélék calicivírus-betegsége elleni, inaktivált vakcina
EA199700353A1 (ru) Композиция и способ для определения приобретенного синдрома иммунодефицита, способ приготовления названной композиции
EP0309898A3 (de) Methode zur Induktion einer zytotoxischen T-Zell-Antwort
IT1233419B (it) Peptidi sintetici immunologicamente attivi utili per la preparazione di un vaccino antimalaria
RU1801212C (ru) Способ отбора детей из группы риска дл ревакцинации против кори
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
Zourbas et al. Immunization of dental surgeons against hepatitis B virus infection.
CA2249736A1 (en) Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee